Brett Sandercock
2018
In 2018, Brett Sandercock earned a total compensation of $2.9M as Chief financial officer at ResMed, a 12% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $355,317 |
|---|---|
| Salary | $454,853 |
| Stock Awards | $2,000,000 |
| Other | $51,220 |
| Total | $2,861,390 |
Sandercock received $2M in stock awards, accounting for 70% of the total pay in 2018.
Sandercock also received $355.3K in non-equity incentive plan, $454.9K in salary and $51.2K in other compensation.
Rankings
In 2018, Brett Sandercock's compensation ranked 4,067th out of 14,244 executives tracked by ExecPay. In other words, Sandercock earned more than 71.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,067 out of 14,244 | 71st |
Division Manufacturing | 1,499 out of 5,765 | 74th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 190 out of 849 | 78th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 104 out of 547 | 81st |
Industry Surgical and Medical Instruments and Apparatus | 66 out of 348 | 81st |
Source: SEC filing on October 3, 2018.
Sandercock's colleagues
We found four more compensation records of executives who worked with Brett Sandercock at ResMed in 2018.